These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30140041)

  • 1. Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells.
    Yang B; Ma YB; Chu SH
    Cancer Gene Ther; 2018 Dec; 25(11-12):309-316. PubMed ID: 30140041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing Temozolomide (TMZ) chemosensitivity using CRISPR-dCas9-mediated downregulation of O
    Yousefi Y; Nejati R; Eslahi A; Alizadeh F; Farrokhi S; Asoodeh A; Mojarrad M
    J Neurooncol; 2024 Aug; 169(1):129-135. PubMed ID: 38762829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Activation of TUSC3 Sensitizes Glioblastoma to Temozolomide Independent of MGMT Promoter Methylation Status.
    Wu Q; Berglund AE; Macaulay RJ; Etame AB
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair/MGMT in glioblastoma.
    Zhao J; Yang S; Cui X; Wang Q; Yang E; Tong F; Hong B; Xiao M; Xin L; Xu C; Tan Y; Kang C
    Neuro Oncol; 2023 May; 25(5):857-870. PubMed ID: 36272139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian regulation of MGMT expression and promoter methylation underlies daily rhythms in TMZ sensitivity in glioblastoma.
    Gonzalez-Aponte MF; Damato AR; Trebucq LL; Simon T; Cárdenas-García SP; Cho K; Patti GJ; Golombek DA; Chiesa JJ; Rubin JB; Herzog ED
    J Neurooncol; 2024 Feb; 166(3):419-430. PubMed ID: 38277015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EPIC-0307-mediated selective disruption of PRADX-EZH2 interaction and enhancement of temozolomide sensitivity to glioblastoma via inhibiting DNA repair and MGMT.
    Xin L; Tan Y; Zhu Y; Cui X; Wang Q; Zhao J; Tian S; Xu C; Xiao M; Hong B; Xu J; Yuan X; Wang C; Kang C; Fang C
    Neuro Oncol; 2023 Nov; 25(11):1976-1988. PubMed ID: 37279651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP19 regulates DNA methylation damage repair and confers temozolomide resistance through MGMT stabilization.
    Liu J; Wang K; Zhu Q; Zhang Y; Chen Y; Lou Z; Yuan J
    CNS Neurosci Ther; 2024 Apr; 30(4):e14711. PubMed ID: 38644551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma.
    Tiek DM; Rone JD; Graham GT; Pannkuk EL; Haddad BR; Riggins RB
    Sci Rep; 2018 May; 8(1):7222. PubMed ID: 29740146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methionine restriction of glioma does not induce MGMT and greatly improves temozolomide efficacy in an orthotopic nude-mouse model: A potential curable approach to a clinically-incurable disease.
    Kubota Y; Aoki Y; Masaki N; Obara K; Hamada K; Han Q; Bouvet M; Tsunoda T; Hoffman RM
    Biochem Biophys Res Commun; 2024 Feb; 695():149418. PubMed ID: 38176171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide DNA methylation analysis identifies potent CpG signature for temzolomide response in non-G-CIMP glioblastomas with unmethylated MGMT promoter: MGMT-dependent roles of GPR81.
    Liang BB; Wang YH; Huang JJ; Lin S; Mao GC; Zhou ZJ; Yan WJ; Shan CY; Wu HZ; Etcheverry A; He YL; Liu FF; Kang HF; Yin AA; Zhang SQ
    CNS Neurosci Ther; 2024 Apr; 30(4):e14465. PubMed ID: 37830163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines.
    Lozinski M; Bowden NA; Graves MC; Fay M; Day BW; Stringer BW; Tooney PA
    Oncotarget; 2024 Jan; 15():1-18. PubMed ID: 38227740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Curcumol reverses temozolomide resistance in glioma cells by regulating the UTX/MGMT axis].
    Sun J; Xing J; Tan R; Qian Y; Tian N
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1697-1705. PubMed ID: 37933645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential gene expression-based connectivity mapping identified novel drug candidate and improved Temozolomide efficacy for Glioblastoma.
    Vengoji R; Atri P; Macha MA; Seshacharyulu P; Perumal N; Mallya K; Liu Y; Smith LM; Rachagani S; Mahapatra S; Ponnusamy MP; Jain M; Batra SK; Shonka N
    J Exp Clin Cancer Res; 2021 Oct; 40(1):335. PubMed ID: 34696786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of TMZ resistance-associated histone post-translational modifications in glioblastoma using multi-omics data.
    Ye L; Gu L; Wang Y; Xing H; Li P; Guo X; Wang Y; Ma W
    CNS Neurosci Ther; 2024 Mar; 30(3):e14649. PubMed ID: 38448295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA MALAT1 knockdown reverses chemoresistance to temozolomide via promoting microRNA-101 in glioblastoma.
    Cai T; Liu Y; Xiao J
    Cancer Med; 2018 Apr; 7(4):1404-1415. PubMed ID: 29479863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of long noncoding RNA
    Okamoto R; Toya K; Ogino Y; Sato A
    Nucleosides Nucleotides Nucleic Acids; 2024; 43(1):86-98. PubMed ID: 37452786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CREB-induced LINC00473 promotes chemoresistance to TMZ in glioblastoma by regulating O6-methylguanine-DNA-methyltransferase expression via CEBPα binding.
    Jiang LY; Wang GH; Xu JJ; Li XL; Lin XY; Fang X; Zhang HX; Feng M; Jiang CM
    Neuropharmacology; 2024 Feb; 243():109790. PubMed ID: 37981063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma.
    Jiapaer S; Furuta T; Tanaka S; Kitabayashi T; Nakada M
    Neurol Med Chir (Tokyo); 2018 Oct; 58(10):405-421. PubMed ID: 30249919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GBP3-STING interaction in glioblastoma coordinates autophagy, anti-oxidative, and DNA repair programs in response to temozolomide.
    Ma J; Wang Z; Chen CC; Li M
    Oncotarget; 2023 May; 14():483-484. PubMed ID: 37204260
    [No Abstract]   [Full Text] [Related]  

  • 20. MGMT inhibition regulates radioresponse in GBM, GSC, and melanoma.
    Yun HS; Kramp TR; Palanichamy K; Tofilon PJ; Camphausen K
    Sci Rep; 2024 May; 14(1):12363. PubMed ID: 38811596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.